Drug Development

SIUOxford: Building Bridges in Biotech between UK-China (Part II)

For Part II of our event series on the UK-China ecosystem for science and technology development, our speakers presented the emerging area of contract research organizations and also highlighted academic initatives such as OSCAR, a university of Oxford led facility established in Suzhou, China.

Bacteria On The Rise: The Fight Against Antibiotic Resistance

Antibiotic resistance is something we hear of a lot these days. What does it actually mean? What causes it? What can we do to stop it? Are we about to enter a stage where we will be helpless against infections once again? In this article SIU brings you all the latest you need to know. 

When The Lab Just Won’t Do: The Use of National Facilities for Biological and Industrial Research

SIU is all about building bridges between academia and industry. National research facilities are the perfect platforms where these bridges can be built. They provide state-of-the-art technologies and are open to both industry and academia. In this article we tell you how they work and how they can lead to new ideas and new companies.

Making Therapeutics Accessible in Developing Countries

According to the World Health Organization, a third of the world's population does not have access to essential medicines. Medicines are expensive, not just because they are very costly to develop but because of many additional factors. In this article we discuss the facts behind the scenes and what can be done to make therapeutics more accessible and affordable in developing countries.

The Call for Cheaper Drug Development

Drug development is a very lengthy and expensive process. Are there ways to make the process easier and cheaper? Here we discuss the current trends in the pharma industry, if these trends are enough to achieve what's in the best interest of the industry, scientists, and most importantly, the patients, and what can be done to improve the situation in the future.